These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 17379435)
21. Two-dimensional vs three-dimensional imaging in whole body oncologic PET/CT: a Discovery-STE phantom and patient study. Bettinardi V; Mancosu P; Danna M; Giovacchini G; Landoni C; Picchio M; Gilardi MC; Savi A; Castiglioni I; Lecchi M; Fazio F Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):214-23. PubMed ID: 17464266 [TBL] [Abstract][Full Text] [Related]
24. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography. Malone JP; Gerberi MA; Vasireddy S; Hughes LF; Rao K; Shevlin B; Kuhn M; Collette D; Tennenhouse J; Robbins KT Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1119-25. PubMed ID: 19917925 [TBL] [Abstract][Full Text] [Related]
25. Usefulness of FDG-PET/CT in the detection of pancreatic metastases from lung cancer. Sato M; Okumura T; Kaito K; Kiyoshima M; Asato Y; Uchiumi K; Iijima H; Hashimoto I; Kaburagi T; Amemiya R Ann Nucl Med; 2009 Jan; 23(1):49-57. PubMed ID: 19205838 [TBL] [Abstract][Full Text] [Related]
26. Usefulness of a breath-holding acquisition method in PET/CT for pulmonary lesions. Yamaguchi T; Ueda O; Hara H; Sakai H; Kida T; Suzuki K; Adachi S; Ishii K Ann Nucl Med; 2009 Jan; 23(1):65-71. PubMed ID: 19205840 [TBL] [Abstract][Full Text] [Related]
27. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data. Martinez-Möller A; Souvatzoglou M; Delso G; Bundschuh RA; Chefd'hotel C; Ziegler SI; Navab N; Schwaiger M; Nekolla SG J Nucl Med; 2009 Apr; 50(4):520-6. PubMed ID: 19289430 [TBL] [Abstract][Full Text] [Related]
28. Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma. Karantanis D; O'Neill BP; Subramaniam RM; Peller PJ; Witte RJ; Mullan BP; Wiseman GA Clin Nucl Med; 2007 Apr; 32(4):271-4. PubMed ID: 17413571 [TBL] [Abstract][Full Text] [Related]
29. Metabolic tumour volume. Prognostic value in locally advanced squamous cell carcinoma of the head and neck. Deron P; Mertens K; Goethals I; Rottey S; Duprez F; De Neve W; Vermeersch H; Van de Wiele C Nuklearmedizin; 2011; 50(4):141-6. PubMed ID: 21594304 [TBL] [Abstract][Full Text] [Related]
30. Optimized contrast-enhanced CT protocols for diagnostic whole-body 18F-FDG PET/CT: technical aspects of single-phase versus multiphase CT imaging. Brechtel K; Klein M; Vogel M; Mueller M; Aschoff P; Beyer T; Eschmann SM; Bares R; Claussen CD; Pfannenberg AC J Nucl Med; 2006 Mar; 47(3):470-6. PubMed ID: 16513616 [TBL] [Abstract][Full Text] [Related]
31. Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma. Quon A; Fischbein NJ; McDougall IR; Le QT; Loo BW; Pinto H; Kaplan MJ J Nucl Med; 2007 Jan; 48 Suppl 1():58S-67S. PubMed ID: 17204721 [TBL] [Abstract][Full Text] [Related]
32. Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging. Scarfone C; Lavely WC; Cmelak AJ; Delbeke D; Martin WH; Billheimer D; Hallahan DE J Nucl Med; 2004 Apr; 45(4):543-52. PubMed ID: 15073248 [TBL] [Abstract][Full Text] [Related]
33. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: diagnostic accuracy and impact on treatment. Bastiaannet E; Wobbes T; Hoekstra OS; van der Jagt EJ; Brouwers AH; Koelemij R; de Klerk JM; Oyen WJ; Meijer S; Hoekstra HJ J Clin Oncol; 2009 Oct; 27(28):4774-80. PubMed ID: 19720925 [TBL] [Abstract][Full Text] [Related]
34. Prospective evaluation of CECT and 18F-FDG-PET/CT in detection of hepatic metastases. D'souza MM; Sharma R; Mondal A; Jaimini A; Tripathi M; Saw SK; Singh D; Mishra A; Tripathi RP Nucl Med Commun; 2009 Feb; 30(2):117-25. PubMed ID: 19057427 [TBL] [Abstract][Full Text] [Related]
35. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy. Tan A; Adelstein DJ; Rybicki LA; Saxton JP; Esclamado RM; Wood BG; Lorenz RR; Strome M; Carroll MA Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):435-40. PubMed ID: 17515501 [TBL] [Abstract][Full Text] [Related]
36. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation. Wykrzykowska J; Lehman S; Williams G; Parker JA; Palmer MR; Varkey S; Kolodny G; Laham R J Nucl Med; 2009 Apr; 50(4):563-8. PubMed ID: 19289431 [TBL] [Abstract][Full Text] [Related]
37. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18. Basu D; Siegel BA; McDonald DJ; Nussenbaum B Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620 [TBL] [Abstract][Full Text] [Related]
38. [The role of whole body 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the management of unknown primary tumors]. Wu ZJ; Zhang YX; Wei H; Jia Q Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2253-6. PubMed ID: 18001544 [TBL] [Abstract][Full Text] [Related]
39. PET/CT for the staging and follow-up of patients with malignancies. Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595 [TBL] [Abstract][Full Text] [Related]
40. Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer. Gourin CG; Watts TL; Williams HT; Patel VS; Bilodeau PA; Coleman TA Laryngoscope; 2008 Apr; 118(4):671-5. PubMed ID: 18197136 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]